肿瘤学冠军将季度收入修订为1 400万加元。 Champions Oncology revises quarterly revenue up to $14.0 million.

Champions Oncology 报告将季度收入修正为 1400 万美元，更新了之前的财务披露。 Champions Oncology reports corrected quarterly revenue of $14.0 million, updating its previous financial disclosure. 该公司侧重于癌症研究和药物开发,作为其正在进行的财务报告的一部分,提供了这一订正数字。 The company, focused on cancer research and drug development, provides this revised figure as part of its ongoing financial reporting. 有关更正的原因或影响的详细信息未在发布稿中列出。 No further details on the correction's cause or impact were included in the release.